Martin Hart alias Dr. Mold & Lyme Chiro

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to advertise Mold illness, often referred to as Chronic Inflammatory Response Syndrome (CIRS), is a complex, multi-system condition triggered by exposure to mold and other biotoxins. as within their scope of practice.

Mold illness, often referred to as Chronic Inflammatory Response Syndrome (CIRS), is a complex, multi-system condition triggered by exposure to mold and other biotoxins.

Supports

There is moderate evidence that exposure to dampness, indoor mold, and microbial growth can be associated with a variety of adverse health effects, including respiratory, allergic, neurologic, and cognitive symptoms, and that these exposures can drive inflammatory and immune responses. Systematic reviews and large epidemiologic analyses have shown consistent associations between indoor dampness/mold and respiratory/allergic outcomes such as asthma, wheeze, hypersensitivity pneumonitis, and other respiratory symptoms, indicating that mold exposure can trigger clinically relevant inflammatory disease in the lungs and airways.^[23] Reviews of immune responses in mold-exposed patients report cellular and humoral immune changes, complement activation, and elevations of inflammatory markers, supporting the premise that mold and mycotoxins can elicit measurable immune dysregulation in some exposed individuals.^[4][5] Recent narrative reviews describe that molds and mycotoxins can induce allergic and non‑allergic chronic inflammatory diseases and may contribute to a dysregulated immune system, particularly in susceptible individuals, suggesting that mold-related illness can involve multi-system inflammatory responses beyond classic allergy.^[2][3] A 2024 review on chronic inflammatory response syndrome (CIRS) describes it as an acquired condition characterized by innate immune dysregulation following exposure to biotoxins from water‑damaged buildings, cyanobacteria, Lyme disease, and other sources, and reports observational data linking chronic indoor microbial growth/dampness to multi-system symptoms (respiratory, neurological, cognitive, dermatologic) with odds ratios or relative risks ≥2.0 in many studies.^[16] Case-series and cohort descriptions of “mold-related illness” have documented severe multi-system sequelae, including autoimmune conditions, multiple chemical sensitivity, and neurocognitive symptoms, in individuals exposed to water‑damaged buildings, consistent with a complex multi-system presentation following mold exposure.^[6][7] Animal studies of mold inhalation demonstrate innate immune activation and neural, cognitive, and emotional dysfunction, providing mechanistic plausibility that mold-associated biotoxins could contribute to multi-system inflammatory and neuroimmune effects in living organisms.^[8] Shoemaker-related literature and reviews summarize repetitive re-exposure trials and clinical protocols in which symptom exacerbations and changes in innate immune markers are temporally associated with biotoxin exposure and treatment, which is presented by these authors as evidence that a chronic biotoxin-driven inflammatory syndrome (CIRS) can be triggered by mold and other biotoxins.^[9][10][16] Overall, existing evidence supports that mold and related biotoxins are capable of provoking immune activation and inflammatory illness, sometimes with multi-system manifestations, particularly in damp, water-damaged indoor environments, and that some authors have conceptualized these multi-system presentations under the label CIRS.

Contradicts

Despite evidence of health effects from mold exposure, the specific construct of “mold illness” or Chronic Inflammatory Response Syndrome (CIRS) as a distinct, widely validated multi-system disease entity remains controversial and is not broadly accepted in mainstream medicine. Major allergy and immunology position papers emphasize that, while the role of molds in asthma, allergic rhinitis, hypersensitivity pneumonitis, and other recognized conditions is well established, evidence is insufficient to support a broad, nonspecific toxic mold syndrome or CIRS caused by inhaled mycotoxins at typical indoor levels.^[14][15][21] Professional toxicology societies and updated guidance documents state that available toxicological evidence does not support inhalation exposure to fungi or mycotoxins in home, school, or office environments as a cause of chronic systemic toxicity or chronic toxic encephalopathy, and that environmental mycotoxin concentrations are orders of magnitude below levels known to cause systemic toxicity.^[13][18][21] These position statements explicitly note that there is no validated diagnostic test or established treatment for systemic toxicity from inhaled indoor mycotoxins, and they caution against attributing diverse, nonspecific multisystem symptoms to chronic mold-related biotoxin illness in the absence of stronger evidence.^[13][18][21] Guidelines and health-plan evidence reviews report that independent researchers have documented immunologic changes in people exposed to damp indoor environments but that these changes have not been shown to constitute a specific disease entity distinct from other chronic multisystem conditions, and that clinical guidelines from major medical societies and government agencies do not recognize CIRS or dampness- and mold-hypersensitivity syndromes as validated diagnostic entities.^[21] Some national and specialty guidelines explicitly recommend against using non-standard diagnostic panels and unvalidated biomarkers commonly promoted for CIRS, citing insufficient scientific evidence and lack of reproducible validation.^[21] The

Mainstream view

Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). ^{[1][2][3][4][5][6][7][8]}

In their own wordsView sourceArchived copy

“Mold illness, often referred to as Chronic Inflammatory Response Syndrome (CIRS), is a complex, multi-system condition triggered by exposure to mold and other biotoxins.”

Rule: ORS 684.010; ORS 684.100; FCLB Oregon summary

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to advertise Chronic Lyme-related illness is best understood as a condition that involves ongoing immune stress and nervous system disruption rather than a single active infection. as within their scope of practice.

Chronic Lyme-related illness is best understood as a condition that involves ongoing immune stress and nervous system disruption rather than a single active infection.

Supports

Several prospective and cross-sectional studies on post-treatment Lyme disease syndrome (PTLDS) and persistent Lyme-related symptoms describe ongoing immune activation rather than ongoing high-burden active infection as a central feature. Elevated interferon-α (IFN-α) levels and other cytokine changes have been documented in patients with persistent symptoms after Lyme neuroborreliosis, supporting a model of maladaptive or persistent immune activation triggered by the initial infection.^[3] One influential review in a major journal explicitly frames posttreatment Lyme disease syndromes as having a distinct pathogenesis driven by maladaptive host immune responses that persist after spirochetal killing with antibiotics, rather than by ongoing infection.^[14] Studies report immune dysregulation such as increased IFN-α activity and differential antibody responses in patients with a history of Lyme disease and persistent cognitive deficits, again pointing to immune stress and neuroimmune involvement rather than clear evidence of active infection.^[2] Anti-neural antibodies and other immunologic abnormalities have been found in patients with post-Lyme disease syndrome, indicating an immune-mediated process that affects the central and peripheral nervous systems and could disrupt nervous system function.^[4] A recent review on dysautonomia following Lyme disease proposes autonomic nervous system dysfunction as a key component of post-treatment symptoms, with hypotheses involving autoantibodies against neural or autonomic targets, which directly aligns with the idea of nervous system disruption driven by immune mechanisms.^[15] Pediatric follow-up studies of neuroborreliosis and PTLDS also emphasize that persistent symptoms occur in a subset despite adequate antibiotic therapy, suggesting long-term neuroimmune consequences rather than uncontrolled infection.^[5][8] More broadly, mechanistic work on chronic stress and its molecular links between endocrine, nervous and immune systems supports the conceptual plausibility that chronic immune activation and stress could drive neuroendocrine and nervous system changes.^[0][1]

Contradicts

Mainstream infectious disease guidelines emphasize that, in most appropriately treated Lyme disease cases, there is no good evidence for ongoing active Borrelia infection as the driver of chronic symptoms, and they specifically recommend against prolonged or repeated antibiotic therapy in patients with persistent nonspecific symptoms unless there is objective evidence of reinfection or treatment failure.^{[16][22][25][19]} Randomized trials of extended antibiotic courses in patients labeled as having chronic Lyme disease or PTLDS have generally failed to show meaningful benefit and have shown potential harms, which argues against a model where a persisting active infection is the primary cause of symptoms, and indirectly challenges influencer narratives that focus on chronic infection as the main mechanism.^[16][22][17] However, while the evidence base supports immune dysregulation and neuroimmune mechanisms, these findings are still incomplete: biomarkers such as IFN-α, IL-23, CCL19, and anti-neural antibodies are not yet sufficiently specific or validated to fully explain all chronic Lyme-related illness, and some reviews caution that PTLDS does not appear to be characterized primarily by excessive immune responses in the same way as postinfectious Lyme arthritis, indicating heterogeneity and remaining uncertainty in the exact pathophysiology.^[14] The available literature acknowledges multiple competing hypotheses, including autoimmunity, persistent antigen or debris, altered pain processing, and psychosocial factors, which means that while immune stress and nervous system disruption are plausible, they are not definitively established as “the” best or only explanatory framework for every patient with chronic Lyme-related symptoms.^[10][17][14]

Mainstream view

The mainstream medical position is that most acute Lyme disease is a treatable bacterial infection that responds well to standard-duration antibiotics, and that a minority of patients experience persistent symptoms such as fatigue, pain, and cognitive difficulties, classified as post-treatment Lyme disease syndrome or related entities rather than ongoing active infection.^{[17][16][22][19]} Major guidelines from infectious disease societies characterize so-called chronic Lyme disease as a poorly defined label and state that there is insufficient evidence to regard it as a distinct ongoing infection requiring prolonged antibiotics.^{[16][19][25][22]} Current expert reviews increasingly view PTLDS and similar chronic Lyme-related syndromes as conditions in which the initial infection triggers complex biological changes—including immune dysregulation, possible autoimmunity, neuroinflammation, and nervous system dysfunction (e.g., dysautonomia)—that can persist after bacterial eradication, although precise mechanisms and subtypes remain under investigation.^{[14][15][17][24]} As a result, mainstream care focuses on symptom management, rehabilitation, and evaluation for overlapping conditions, while research continues into immune and neuroimmune mechanisms; the dominant view is that persistent symptoms are real and biologically mediated, but are not best explained as a simple ongoing active Borrelia infection in most cases Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Chronic Lyme-related illness is best understood as a condition that involves ongoing immune stress and nervous system disruption rather than a single active infection.”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Dr. Hart works extensively with individuals facing inflammation, autoimmunity, chronic fatigue, gut dysfunction, mineral imbalances, and environmentally driven illness..

Dr. Hart works extensively with individuals facing inflammation, autoimmunity, chronic fatigue, gut dysfunction, mineral imbalances, and environmentally driven illness.

Supports

The index papers support that fatigue is common in chronic illness and that fatigue-focused self-management interventions can help some patients with chronic conditions. ^{[19][20][22][24]} The systematic review on older individuals with chronic illness describes fatigue as a frequent problem and is framed as clinically relevant to patients and clinicians. ^[17] The systematic review and meta-analysis of fatigue self-management led by occupational therapists and/or physiotherapists found a modest pooled benefit versus usual care/no intervention, with mixed results across outcomes and substantial heterogeneity. ^[18][21][23] The broader literature also supports that fatigue is prevalent across many chronic diseases and is often studied in relation to inflammatory and immune-mediated conditions, which is directionally consistent with the claim’s symptom domains.

Contradicts

The claim is about Dr. Hart working extensively with individuals facing inflammation, autoimmunity, gut dysfunction, mineral imbalances, and environmentally driven illness, but the provided index papers do not establish that this specific clinician works extensively in those areas. They address fatigue in chronic illness and fatigue management in rehabilitation, not a practice profile or caseload distribution. ^{[17][18][20][24]} Evidence for the broader cluster of explanations invoked by the claim is also uneven: the OT/PT fatigue self-management review found heterogeneity and mixed effects, so it does not justify broad disease-specific or mechanism-specific claims. ^{[19][21][22][23]} The gut-immune-brain axis chapter is a conceptual review chapter rather than high-quality clinical evidence, and it does not demonstrate that environmental illness or mineral imbalance are established, routine clinical categories for this context. The evidence base therefore supports fatigue management in chronic conditions more strongly than it supports the full breadth of the influencer’s framing.

Mainstream view

Mainstream medicine recognizes fatigue as a common, burdensome symptom across many chronic illnesses, including autoimmune and inflammatory diseases, and supports multidisciplinary management when appropriate. ^{[17][18][20][21][23][24]} However, the specific bundle of claims about extensive work with inflammation, autoimmunity, gut dysfunction, mineral imbalances, and environmentally driven illness is too broad to infer from the cited evidence and is not established as a standard, unified medical category. ^[19] The strongest evidence here is for symptom-focused care in chronic conditions, not for validating a comprehensive alternative explanatory framework or for inferring the clinician’s actual scope of practice from these papers.

In their own wordsView sourceArchived copy

“Dr. Hart works extensively with individuals facing inflammation, autoimmunity, chronic fatigue, gut dysfunction, mineral imbalances, and environmentally driven illness.”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure PANS/PANDAS.

PANS/PANDAS

Supports

PANS and PANDAS are recognized clinical syndromes in pediatric neuropsychiatry, with abrupt-onset OCD or tic symptoms and associated behavioral changes described in consensus literature and the recent AAP clinical report. ^{[25][29][30][31][32]} The AAP report states PANS is a valid diagnosis and recommends multidisciplinary assessment and symptom-focused care, including CBT and treatment of documented streptococcal infection. Consensus guidelines from the PANS Research Consortium also support psychiatric, behavioral, and selected medical treatments as pragmatic management approaches, although these are based largely on expert consensus rather than strong trial evidence. ^[27]

Contradicts

The evidence base for PANS/PANDAS-specific disease mechanisms and treatments is limited. ^[30] Earlier reviews note that definitive proof of the autoimmune hypothesis is lacking and that evidence for interventions is weak or inconsistent. ^[29][31] The AAP clinical report says invasive immunotherapies are usually not recommended because of lack of evidence and potential adverse effects, and that immunomodulatory therapies should be used only in rare cases after multispecialty consultation. ^[25] A prior evidence review commissioned for coverage decisions found insufficient comparative evidence for prophylactic antibiotics and only weak support for some immunomodulatory approaches. Much of the published guidance comes from consensus statements rather than high-quality randomized evidence, so the mainstream literature does not treat PANS/PANDAS as a fully established biomarker-defined autoimmune disorder with proven disease-specific therapy.

Mainstream view

The mainstream medical view is that PANS is a real clinical syndrome characterized by abrupt neuropsychiatric onset, but PANDAS/PANS remain controversial in etiology and lack definitive biomarkers or robust treatment evidence. ^{[25][29][30][31][32]} Current practice emphasizes careful differential diagnosis, psychiatric/behavioral treatment, and treating confirmed infections, while reserving immunomodulatory therapies for selected severe cases under specialist oversight.

In their own wordsView sourceArchived copy

“PANS/PANDAS”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Hashimoto's thyroiditis.

Hashimoto's thyroiditis

Supports

High-quality evidence shows that some nutritional and supplement interventions can modestly improve biochemical markers in Hashimoto’s thyroiditis, but mainly as adjuncts to standard levothyroxine therapy rather than standalone cures. ^[38] The 2023 systematic review on nutritional interventions reports that energy restriction, elimination of gluten or lactose in selected patients, Nigella sativa, and reduction of goitrogens were associated with improvements in TSH, free T4, and anti-TPO antibodies in small, heterogeneous studies, suggesting diet may be a complementary treatment. A systematic review and meta-analysis of randomized clinical trials on selenium supplementation in Hashimoto’s thyroiditis found that selenium (typically 80–200 μg/day, often as selenomethionine) significantly lowered TSH and TPO antibodies in patients not yet on thyroid hormone replacement, with moderate-certainty evidence and acceptable short‑term safety. ^[34][40] A 2024 systematic review and network meta-analysis of different supplements in Hashimoto’s thyroiditis reported that selenium was the only supplement with consistent, significant reductions in TPO and thyroglobulin antibodies compared with placebo, supporting its role as an auxiliary treatment during standard care. ^{[33][36][37][39]} Epidemiologic evidence from the global prevalence meta-analysis confirms that Hashimoto’s thyroiditis is a common autoimmune cause of hypothyroidism worldwide, aligning with claims that it is a major public health concern. ^[35]

Contradicts

The nutritional intervention systematic review emphasizes that the evidence base is small, heterogeneous, and methodologically weak, and concludes that further experimental studies are needed before any specific diet can be recommended as definitively beneficial for Hashimoto’s disease. ^{[33][35][37][38][39]} This cautions against strong claims that particular diets (e. g. , universal gluten‑free or lactose‑free diets) reliably treat the disease in all patients. The selenium meta-analysis, while positive, shows only modest effect sizes and was limited to short‑term biochemical outcomes, not long‑term clinical endpoints such as progression of hypothyroidism, quality of life, or hard outcomes, meaning strong curative or disease‑reversing claims are not supported. ^[34] The network meta-analysis similarly focuses on antibody titers and TSH, and does not establish that supplements alter the natural history of Hashimoto’s or obviate the need for levothyroxine. ^[36] Major thyroid guidelines and expert reviews (outside the index list) generally do not recommend routine selenium or other supplements for all Hashimoto’s patients, reflecting concern over heterogeneous trial results, potential toxicity at higher doses, and lack of long‑term outcome data; this contradicts any influencer claim that selenium or diet alone is a proven treatment or cure. ^[40] If an influencer claims that Hashimoto’s is fully reversible in most cases through nutrition and supplements, that is not supported by the current systematic reviews, which frame these strategies as adjunctive and experimental rather than curative.

Mainstream view

Mainstream medical practice views Hashimoto’s thyroiditis as a chronic autoimmune thyroid disease that frequently leads to permanent hypothyroidism requiring long‑term levothyroxine replacement to normalize TSH and free thyroid hormone levels. ^[38][39] Nutritional factors and micronutrient status (including selenium, vitamin D, iodine, iron, and others) are recognized as potentially relevant to thyroid autoimmunity, and correcting clear deficiencies is considered reasonable, but diets and supplements are regarded as adjunctive measures rather than primary therapy. Selenium supplementation may be considered in selected patients with Hashimoto’s thyroiditis who are not on thyroid hormone and who may have low selenium status, as recent meta-analyses and network meta-analyses show modest reductions in antibodies and TSH, but routine universal supplementation is not standard of care due to limited clinical outcome data and safety concerns. ^{[34][35][36][40]} Overall, the mainstream position is that Hashimoto’s thyroiditis is common and often progressive, that levothyroxine is the evidence‑based cornerstone of treatment when hypothyroidism is present, and that nutrition and supplements can be explored on an individualized basis but should not be presented as proven cures or replacements for hormone therapy. ^[33][37]

In their own wordsView sourceArchived copy

“Hashimoto's thyroiditis”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure rheumatoid arthritis.

rheumatoid arthritis

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“rheumatoid arthritis”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure lupus.

lupus

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“lupus”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to advertise I am in remission of Lyme Disease and the above illnesses. as within their scope of practice.

I am in remission of Lyme Disease and the above illnesses.

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“I am in remission of Lyme Disease and the above illnesses.”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Mold Illness (CIRS).

Mold Illness (CIRS)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Mold Illness (CIRS)”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Lyme Disease.

Lyme Disease

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Lyme Disease”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure MCAS & Histamine Issues.

MCAS & Histamine Issues

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“MCAS & Histamine Issues”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmunity.

Autoimmunity

Supports

The index papers support that fatigue is common in chronic illness and that fatigue-focused self-management interventions can help some patients with chronic conditions. ^{[19][20][22][24]} The systematic review on older individuals with chronic illness describes fatigue as a frequent problem and is framed as clinically relevant to patients and clinicians. ^[17] The systematic review and meta-analysis of fatigue self-management led by occupational therapists and/or physiotherapists found a modest pooled benefit versus usual care/no intervention, with mixed results across outcomes and substantial heterogeneity. ^[18][21][23] The broader literature also supports that fatigue is prevalent across many chronic diseases and is often studied in relation to inflammatory and immune-mediated conditions, which is directionally consistent with the claim’s symptom domains.

Contradicts

The claim is about Dr. Hart working extensively with individuals facing inflammation, autoimmunity, gut dysfunction, mineral imbalances, and environmentally driven illness, but the provided index papers do not establish that this specific clinician works extensively in those areas. They address fatigue in chronic illness and fatigue management in rehabilitation, not a practice profile or caseload distribution. ^{[17][18][20][24]} Evidence for the broader cluster of explanations invoked by the claim is also uneven: the OT/PT fatigue self-management review found heterogeneity and mixed effects, so it does not justify broad disease-specific or mechanism-specific claims. ^{[19][21][22][23]} The gut-immune-brain axis chapter is a conceptual review chapter rather than high-quality clinical evidence, and it does not demonstrate that environmental illness or mineral imbalance are established, routine clinical categories for this context. The evidence base therefore supports fatigue management in chronic conditions more strongly than it supports the full breadth of the influencer’s framing.

Mainstream view

Mainstream medicine recognizes fatigue as a common, burdensome symptom across many chronic illnesses, including autoimmune and inflammatory diseases, and supports multidisciplinary management when appropriate. ^{[17][18][20][21][23][24]} However, the specific bundle of claims about extensive work with inflammation, autoimmunity, gut dysfunction, mineral imbalances, and environmentally driven illness is too broad to infer from the cited evidence and is not established as a standard, unified medical category. ^[19] The strongest evidence here is for symptom-focused care in chronic conditions, not for validating a comprehensive alternative explanatory framework or for inferring the clinician’s actual scope of practice from these papers.

In their own wordsView sourceArchived copy

“Autoimmunity”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Chronic Fatigue.

Chronic Fatigue

Supports

The index papers support that fatigue is common in chronic illness and that fatigue-focused self-management interventions can help some patients with chronic conditions. ^{[19][20][22][24]} The systematic review on older individuals with chronic illness describes fatigue as a frequent problem and is framed as clinically relevant to patients and clinicians. ^[17] The systematic review and meta-analysis of fatigue self-management led by occupational therapists and/or physiotherapists found a modest pooled benefit versus usual care/no intervention, with mixed results across outcomes and substantial heterogeneity. ^[18][21][23] The broader literature also supports that fatigue is prevalent across many chronic diseases and is often studied in relation to inflammatory and immune-mediated conditions, which is directionally consistent with the claim’s symptom domains.

Contradicts

The claim is about Dr. Hart working extensively with individuals facing inflammation, autoimmunity, gut dysfunction, mineral imbalances, and environmentally driven illness, but the provided index papers do not establish that this specific clinician works extensively in those areas. They address fatigue in chronic illness and fatigue management in rehabilitation, not a practice profile or caseload distribution. ^{[17][18][20][24]} Evidence for the broader cluster of explanations invoked by the claim is also uneven: the OT/PT fatigue self-management review found heterogeneity and mixed effects, so it does not justify broad disease-specific or mechanism-specific claims. ^{[19][21][22][23]} The gut-immune-brain axis chapter is a conceptual review chapter rather than high-quality clinical evidence, and it does not demonstrate that environmental illness or mineral imbalance are established, routine clinical categories for this context. The evidence base therefore supports fatigue management in chronic conditions more strongly than it supports the full breadth of the influencer’s framing.

Mainstream view

Mainstream medicine recognizes fatigue as a common, burdensome symptom across many chronic illnesses, including autoimmune and inflammatory diseases, and supports multidisciplinary management when appropriate. ^{[17][18][20][21][23][24]} However, the specific bundle of claims about extensive work with inflammation, autoimmunity, gut dysfunction, mineral imbalances, and environmentally driven illness is too broad to infer from the cited evidence and is not established as a standard, unified medical category. ^[19] The strongest evidence here is for symptom-focused care in chronic conditions, not for validating a comprehensive alternative explanatory framework or for inferring the clinician’s actual scope of practice from these papers.

In their own wordsView sourceArchived copy

“Chronic Fatigue”

Rule: ORS 684.010; ORS 684.100

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to advertise Mold illness and CIRS as within their scope of practice.

Mold illness and CIRS

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Mold illness and CIRS”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to advertise Lyme disease and co-infections as within their scope of practice.

Lyme disease and co-infections

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Lyme disease and co-infections”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmune and immune dysregulation.

Autoimmune and immune dysregulation

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Autoimmune and immune dysregulation”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Thyroid and hormone imbalances.

Thyroid and hormone imbalances

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Thyroid and hormone imbalances”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Chronic fatigue and low energy.

Chronic fatigue and low energy

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Chronic fatigue and low energy”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Gut disorders - SIBO/SIFO.

Gut disorders - SIBO/SIFO

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Gut disorders - SIBO/SIFO”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Pediatric PANS and PANDAS.

Pediatric PANS and PANDAS

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Pediatric PANS and PANDAS”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to advertise What Is Mold Illness (CIRS)? as within their scope of practice.

What Is Mold Illness (CIRS)?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“What Is Mold Illness (CIRS)?”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to advertise What Is Lyme Disease? as within their scope of practice.

What Is Lyme Disease?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“What Is Lyme Disease?”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to advertise Meet Our Mold-Literate & Lyme-Literate Practitioners as within their scope of practice.

Meet Our Mold-Literate & Lyme-Literate Practitioners

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Meet Our Mold-Literate & Lyme-Literate Practitioners”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Martin Hart is not licensed or approved by Oregon Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmune.

Autoimmune

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Autoimmune”

Rule: Oregon Chiropractic Practice Act (scope limited to musculoskeletal/spine care)